Who we are
A unique force in the pharmaceutical industry
Merck Serono combines its complementary expertise in new chemical entities (NCEs) and new biological entities (NBEs) to offer innovative prescription drugs of either origin.
With comprehensive skills in all areas from research and development to manufacturing, marketing and sales, the division offers its world-class products in over 150 countries worldwide. Our strategically positioned workforce of 8,000 sales and marketing employees ensures commercial coverage in the U.S. and Canada, Latin America, Europe, Asia-Pacific and Japan.
In the UK we are building a local strategy to meet the demands within the UK health systems. Over the past year we have changed the organisation to reflect these changes for the future.
With comprehensive skills in all areas from research and development to manufacturing, marketing and sales, the division offers its world-class products in over 150 countries worldwide. Our strategically positioned workforce of 8,000 sales and marketing employees ensures commercial coverage in the U.S. and Canada, Latin America, Europe, Asia-Pacific and Japan.
In the UK we are building a local strategy to meet the demands within the UK health systems. Over the past year we have changed the organisation to reflect these changes for the future.
We aim to
- Become a world leader in health technology
- Support the healthcare community to understand the technologies and to maximise the health gain for our patients
We will invest resources to ensure support in the following areas
- Genetic testing to identify responders to therapies
- Technologies to enhance adherence
- Nurse programmes to support patients
In the UK
- Patients are our focus
- Healthcare Decision Makers are our priorities’
- Improved Healthcare is our Goal
Merck Serono UK are developing a legacy:
‘What we do with our technologies has a direct impact on you and your patients.’
‘What we do with our technologies has a direct impact on you and your patients.’
